Results 91 to 100 of about 12,603 (200)
Cariprazine in Schizophrenia: Clinical Efficacy, Tolerability, and Place in Therapy [PDF]
Cariprazine is a dopamine D3-preferring D3/D2 receptor partial agonist in late-stage clinical development for the treatment of schizophrenia, as well as for bipolar disorder (manic/mixed and depressive episodes), and as an adjunctive agent for the ...
Leslie Citrome
core +1 more source
Nanotechnology versus other techniques in improving drug dissolution [PDF]
postprin
Chan, HK, Kwok, PCL
core +1 more source
Objective. The aim of the present study was to find out whether acute effect of different doses of selected antipsychotics including aripiprazole (ARI), amisulpride (AMI), asenapine (ASE), haloperidol (HAL), clozapine (CLO), risperidone (RIS), quetiapine
Kiss Alexander
doaj +1 more source
Medication and suicide risk in schizophrenia: A nested case-control study
Introduction: Patients with schizophrenia are at increased risk of suicide, but data from controlled studies of pharmacotherapy in relation to suicide risk is limited.
Bahmanyar, S. +6 more
core +1 more source
The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review [PDF]
Norepinephrine (NE) is recognized as having a key role in the pathophysiology of major depressive disorder (MDD) and schizophrenia, although its distinct actions via α-adrenergic receptors (α-ARs) are not well defined.
Anna Eramo +4 more
core +1 more source
Charles L BowdenMood & Anxiety Disorder Division, Department of Psychiatry, UT Health Science Center, San Antonio, TX, USAObjectives: This article addresses the clinical role for ziprasidone used adjunctively with a mood stabilizer in maintenance
Charles L Bowden
doaj
Urooj A Khan,1 Uzma Parveen,2 Nazeer Hasan,1 Mohammad Zubair Ahmed,1 Suma Saad,1 Farhan J Ahmad,1 Gaurav K Jain1 1Nanoformulation Research Laboratory, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi ...
Khan UA +6 more
doaj
Commentary on strategies for switching antipsychotics [PDF]
Both the new generation of antipsychotics and the more traditional antipsychotic drugs produce an important and meaningful improvement in patients with schizophrenia, but most patients are neither cured nor free of symptoms.
John M Davis +11 more
core +1 more source
Atypical antipsychotics in the treatment of early-onset schizophrenia
Michal Hrdlicka, Iva Dudova Department of Child Psychiatry, Charles University Second Faculty of Medicine and University Hospital Motol, Prague, Czech Republic Abstract: Atypical antipsychotics (AAPs) have been successfully used in early-onset ...
Hrdlicka M, Dudova I
doaj
Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?
Background Since schizophrenia is considered one of the top ten causes of disease-related disability in the world, the development of second-generation (atypical) antipsychotics (SGAs) has increased the hopes of psychiatrists.
Chiara Mattei +2 more
doaj +1 more source

